47 results found.
    
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
Wright Medical Grew 11.8% in 2Q19 Amid Cartiva Woes
Wright Medical reports 2Q19 revenue of USD $229.7MM, +11.8% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Wright Medical Reports 1Q19 Revenue of $230.1MM, +15.9% vs. 1Q18
Wright Medical reports 1Q19 revenue of USD $230.1MM, +15.9% vs. 1Q18.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Wright Medical Reports 4Q18 Revenue of $238.1MM, +9.4% vs. 4Q17
Wright Medical reports 4Q18 revenue of USD $238.1MM, +9.4% vs. 4Q17, with 2018 full year revenue of
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical Report Preliminary 4Q18 and FY 2018 Results
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical reported preliminary 4Q18 and FY 2018 results.
Investors Prioritize Care Delivery, Post-Revenue Companies
By Carolyn LaWell Extremities, sports medicine, digital health and the hospital supply chain remain attractive areas for orthopaedic innovation, according to investors who spoke during the Musculoskeletal New Ventures Conference (MNVC) held in October. This seems like a natural course, ...
Wright Medical Reports 3Q18 Revenue of $194.1MM, +13.8% vs. 3Q17
Wright Medical reports 3Q18 revenue of US $194.1MM, +13.8% vs. 3Q17.
Wright Medical Completes Cartiva Acquisition
Wright Medical completed its acquisition of Cartiva, developer of the Synthetic Cartilage Implant.
Wright Medical Acquiring Cartiva
Wright Medical is acquiring Cartiva, a manufacturer of the Synthetic Cartilage Implant to treat arthritis in the great toe, for US $435MM. The transaction i...
Arthroscopy/Soft Tissue Repair Market Ripe for 6% Growth
By Carolyn LaWell Sales from arthroscopy/soft tissue repair products in 2017 surpassed $5.3 billion and grew 6.2% vs. 2016, according to our estimates published in
Cartiva Synthetic Cartilage Implant Long-Term Clinical Data
Five-year follow-up results demonstrate that Cartiva's Synthetic Cartilage Implant provided long-term durability in pain and f...
Cartiva Treats First US Patient in Thumb OA Study
Cartiva treated the first U.S. patient in a study evaluating the Synthetic Cartilage Implant to treat first carpometac...
1H17 Funding Recap: Investors Continue to Back Regulatory-Approved Orthopaedic Technologies
The 24 funding announcements we tracked by orthopaedic companies in 1H17 kept pace with the number of announcements made in the first halves of 2016 and 2015, signaling that the environment to raise capital remains consistent, but difficult. Risk-adverse private equity, venture capital and other ...
Patient Enrollment Complete in Thumb OA Study of Cartiva SCI
Cartiva completed enrollment and treatment of all 50 patients in a multi-center study evaluating the...
5-Year Clinical Data on Cartiva Synthetic Cartilage Implant
Five-year results from a clinical trial of the Cartiva Synthetic Cartilage Implant in the treatment of great toe arthritis
Cartiva Secures $8.5MM Funding
Cartiva secured US $8.5MM in a Series E financing. Proceeds will support commercialization of the Synthetic Cartilage Impl...
2016: The Year in Products and Services
Editor's Note: “Keep me informed on what everyone is doing” is, without fail, one request returned in every ORTHOWORLD Membership Survey. In seeking to do just that, let’s get a jump on one yearly recap: product launches. (Spine wi...
First U.S. Procedure with Cartiva Synthetic Cartilage Implant
The first commercial U.S. patient has received the Cartiva Synthetic Cartilage Implant following its FDA Premarket Approval
Cartiva Announces FDA Premarket Approval for Cartiva Synthetic Cartilage Implant
Cartiva received FDA Premarket Approval for the Synthetic Cartilage Implant to treat arthritis of the g...
Cartiva Announces Positive FDA Advisory Panel Review of Synthetic Cartilage Implant
FDA's Orthopaedic and Rehabilitation Devices Panel recommended premarket approval of Cartiva's Synthetic Cartilage Implan...
FDA Panel to Convene on PMA for Cartiva's Synthetic Cartilage Implant
On 4/20/16, FDA's Orthopaedic and Rehabilitation Devices Panel will meet regarding the PMA for Cartiva's Sy...
Tentative Date for FDA Advisory Panel Review of Cartiva SCI
FDA tentatively scheduled a 2Q16 meeting of the Orthopaedic and Rehabilitation Devices Panel to review Cartiva's Premarket A...
BARE BONES® - September 25, 2015
Cartiva announced the 1st patient treated in GRIP, a multi-center study evaluating the Synthetic Cartilage Implant in the treatment of 1st carpometacarpal joint osteoarthritis at the base of t...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group